Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2937-2940

  Guerin, M ^a   Bara, C ^a   Celerier P ^a   Maillard, H ^a   Haettich, B ^a   Artru, L ^a   Prophette, B ^a  

^a General Hospital of le Mans   (France)

Author keywords

Anti TNF therapy; Induced lupus; Interstitial granulomatous dermatitis; Palisaded neutrophilic and granulomatous dermatitis; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

ADALIMUMAB; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DNA ANTIBODY; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PHOSPHOLIPID ANTIBODY; SULFALAZINE;

ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; B LYMPHOCYTE; CASE REPORT; CELL INFILTRATION; CORTICOSTEROID THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL GRANULOMATOUS DERMATITIS; MYALGIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SEDIMENTATION RATE; SKIN INFLAMMATION; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; BIOPSY; COMORBIDITY; DERMATITIS; FEMALE; GRANULOMA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866364738     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2016-6     Document Type: Article

References (15)

1. Dykman CJ, Galens GJ, Good AE (1965) Linear subcutaneous bands in rheumatoid arthritis. An unusual form of rheumatoid granuloma. Ann Intern Med 63:134-140
2. Ackerman AB, Guo Y, Vitale P, Vossaert K (1993) Clues to diagnosis in dermatopathology, vol 3. ASCP Press, Chicago
3. Bremner R, Simpson E, White CR, Morrison L, Deodhar A (2004) Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum 34(3):610-616 (Pubitemid 39643123)
4. Chu P, Connolly MK, LeBoit PE (1994) The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 130(10):1278-1283 (Pubitemid 24313287)
5. Magro CM, Crowson AN, Schapiro BL (1998) The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 25(2):72-78 (Pubitemid 28073644)
6. Perrin C, Lacour JP, Castanet J, Michiels JF (2001) Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am J Dermatopathol 23(4):295-298 (Pubitemid 32729437)
7. Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM et al (2006) Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 142(2):198-202 (Pubitemid 43276531)
8. Hu S, Cohen D, Murphy G, Mody E, Qureshi AA (2008) Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept. Cutis 81(4):336-338
9. Zoli A, Massi G, Pinnelli M, Lo Cuccio CD, Castri F, Ferraccioli G (2010) Interstitial granulomatous dermatitis in rheumatoid arthritis responsive to etanercept. Clin Rheumatol 29(1):99-101
10. Vedove CD, Del Giglio M, Schena D, Girolomoni G (2009) Drug-induced lupus erythematosus. Arch Dermatol Res 301(1): 99-105
11. Borchers AT, Keen CL, Gershwin ME (2007) Drug-induced lupus. Ann N Y Acad Sci 1108:166-182 (Pubitemid 47528730)
12. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C et al (2005) Systemic lupus erythematosus induced by antitumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 7(3):R545-R551
13. Benucci M, Li Gobbi F, Fossi F, Manfredi M, Del Rosso A (2005) Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. J Clin Rheumatol 11(1):47-49 (Pubitemid 40223880)
14. Haraoui B, Keystone E (2006) Musculoskeletal manifestations and autoimmune diseases related to new biologic agents. Curr Opin Rheumatol 18(1):96-100 (Pubitemid 43740411)
15. Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD et al (2004) The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 126(1):19-31 (Pubitemid 38040720)